Coherus BioSciences Inc. News
FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.
Coherus was cleared by the FDA for a drug that's similar to AbbVie's Humira. Coherus plans to launch the psoriasis treatment in July 2023.
Five Below, Splunk, Snap: 'Mad Money' Lightning Round
Jim Cramer weighs in on Five Below, Splunk, Snap, Crown Castle, Square, 3D Systems, Dana, Alibaba, Coherus Biosciences.
Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
Even with Monday's sharp reversal, Jim Cramer says he still likes this market.
Here's what blackstone bought and sold in the fourth quarter
Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.
Tesla Stock Lower After Data Shows July China Sales Slump
Tesla sold just over 28,000 China-made cars last month, an industry lobby group said Tuesday.
Novavax Stock Plummets After Slashing 2022 Vaccine Sales Forecast
"I believe we were late to the market and US vaccination was driven by what was available and shown to work," said Novavax CEO Stanley Erck.
Bed Bath & Beyond Stock Turns Lower Following Short Squeeze Surge
Suggestions of a Reddit-fueled short-squeeze have shares in struggling home retailer Bed, Bath & Beyond back on the move Tuesday.
Micron Technology Stock Tumbles On Reduced Q4 Chip Sales Forecast
"In FQ1, bit shipments are now expected to decline sequentially, and we expect significant sequential declines in revenue and margins," Micron said.